Your AI-Trained Oncology Knowledge Connection!
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital
Articles
Future of BCMA-Targeted Therapies in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Bispecific Antibodies for Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Differentiating among CAR T Products for Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Development of CAR T Cells in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Using Antibody-Drug Conjugates in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
BCMA-Targeted Therapies in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
BELLINI Trial; Venetoclax-Vd in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
BOSTON Study; SVd in Relapsed/Refractory Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Lenalidomide-Refractory Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Daratumumab With Carfilzomib in Frontline Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Management of Relapsed/Refractory Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Maintenance Therapy Approaches in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
MRD Monitoring in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
The Role of Transplant in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Treating Transplant-Eligible and -Ineligible MM
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Transplant-Ineligible Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Tolerability of Triplet Therapy in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Frontline Triplet Therapies in Multiple Myeloma
Keith Stewart, MB, CHB, UHN and Princess Margaret Hospital;Natalie S. Callander, MD, University of Washington Carbone Cancer Center ;Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Noopur Raje, MD, Massachusetts General Hospital;Peter Voorhees, MD, Atrium Health
July 17th 2020Read More
Latest Updated Articles
Published: January 22nd 2025 | Updated: February 14th 2025
Efficacy of RLY-2608, a mutant-selective PI3Kα inhibitor, in patients with PIK3CA-mutant HR+HER2- advanced breast cancer: ReDiscover trial
Published: February 11th 2025 | Updated: February 14th 2025
Tagraxofusp Achieves Anti-Tumor Activity with Rapid Restoration of Normal Hematopoiesis in Treatment-Naïve Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Subanalysis of a Pivotal Trial
Published: December 24th 2024 | Updated: January 28th 2025
Brief Overview of Synovial Sarcoma: What It Is, Clinical Presentation and Diagnosis
Published: December 17th 2024 | Updated: January 16th 2025
Real-world comparison of the efficacy and safety of atezolizumab versus durvalumab in extensive-stage small cell lung cancer
Published: January 6th 2025 | Updated: January 8th 2025
Second-Line Ropeginterferon Alfa-2b Boosts Responses in Essential Thrombocythemia
Published: December 3rd 2024 | Updated: December 6th 2024
ASH 2024 Preview for Medical Oncologists: The Show and After Show
